289 related articles for article (PubMed ID: 20478780)
41. [Li-Fraumeni syndrome].
Tsunematsu Y
Nihon Rinsho; 2000 Jul; 58(7):1442-7. PubMed ID: 10921321
[TBL] [Abstract][Full Text] [Related]
42. TP53 mutation and haplotype analysis of two large African American families.
Hung J; Mims B; Lozano G; Strong L; Harvey C; Chen TT; Stastny V; Tomlinson G
Hum Mutat; 1999; 14(3):216-21. PubMed ID: 10477429
[TBL] [Abstract][Full Text] [Related]
43. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome.
Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH
Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993
[TBL] [Abstract][Full Text] [Related]
44. Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene.
Bougeard G; Brugières L; Chompret A; Gesta P; Charbonnier F; Valent A; Martin C; Raux G; Feunteun J; Bressac-de Paillerets B; Frébourg T
Oncogene; 2003 Feb; 22(6):840-6. PubMed ID: 12584563
[TBL] [Abstract][Full Text] [Related]
45. [Radiation-induced intracranial osteosarcoma after radiation for acute lymphocytic leukemia associated with Li-Fraumeni syndrome].
Yoshimura J; Natsumeda M; Nishihira Y; Nishiyama K; Saito A; Okamoto K; Takahashi H; Fujii Y
No Shinkei Geka; 2013 Jun; 41(6):499-505. PubMed ID: 23732761
[TBL] [Abstract][Full Text] [Related]
46. p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome.
Quesnel S; Verselis S; Portwine C; Garber J; White M; Feunteun J; Malkin D; Li FP
Oncogene; 1999 Jul; 18(27):3970-8. PubMed ID: 10435620
[TBL] [Abstract][Full Text] [Related]
47. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.
Tabori U; Nanda S; Druker H; Lees J; Malkin D
Cancer Res; 2007 Feb; 67(4):1415-8. PubMed ID: 17308077
[TBL] [Abstract][Full Text] [Related]
48. High frequency of de novo mutations in Li-Fraumeni syndrome.
Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
[TBL] [Abstract][Full Text] [Related]
49. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
50. Li-Fraumeni syndrome in a Malaysian kindred.
Ariffin H; Martel-Planche G; Daud SS; Ibrahim K; Hainaut P
Cancer Genet Cytogenet; 2008 Oct; 186(1):49-53. PubMed ID: 18786442
[TBL] [Abstract][Full Text] [Related]
51. [Li-Fraumeni syndrome].
Tokunaga A; Onda M; Matsukura N; Kato S
Nihon Rinsho; 1995 Nov; 53(11):2797-802. PubMed ID: 8538047
[TBL] [Abstract][Full Text] [Related]
52. The first documentation of Li-Fraumeni syndrome in Korea.
Bang YJ; Kang SH; Kim TY; Jung CW; Oh SM; Choe KJ; Kim NK
J Korean Med Sci; 1995 Jun; 10(3):205-10. PubMed ID: 8527048
[TBL] [Abstract][Full Text] [Related]
53. Genetic counseling can influence the course of a suspected familial cancer syndrome patient: from a case of Li-Fraumeni like syndrome with a germline mutation in the TP53 gene.
Hwang SM; Lee ES; Shin SH; Kong SY
Korean J Lab Med; 2008 Dec; 28(6):493-7. PubMed ID: 19127115
[TBL] [Abstract][Full Text] [Related]
54. Li-Fraumeni syndrome and the role of the pediatric nurse practitioner.
Parsons M
Clin J Oncol Nurs; 2011 Feb; 15(1):79-87. PubMed ID: 21278043
[TBL] [Abstract][Full Text] [Related]
55. Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations.
Choong SS; Latiff ZA; Mohamed M; Lim LL; Chen KS; Vengidasan L; Razali H; Abdul Rahman EJ; Ariffin H;
Clin Genet; 2012 Dec; 82(6):564-8. PubMed ID: 22233476
[TBL] [Abstract][Full Text] [Related]
56. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D
Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma.
Toguchida J; Yamaguchi T; Dayton SH; Beauchamp RL; Herrera GE; Ishizaki K; Yamamuro T; Meyers PA; Little JB; Sasaki MS
N Engl J Med; 1992 May; 326(20):1301-8. PubMed ID: 1565143
[TBL] [Abstract][Full Text] [Related]
58. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
[TBL] [Abstract][Full Text] [Related]
59. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.
Ognjanovic S; Olivier M; Bergemann TL; Hainaut P
Cancer; 2012 Mar; 118(5):1387-96. PubMed ID: 21837677
[TBL] [Abstract][Full Text] [Related]
60. Multiple primary tumors in a family with Li-Fraumeni syndrome with a TP53 germline mutation identified by next-generation sequencing.
Zampiga V; Danesi R; Tedaldi G; Tebaldi M; Cangini I; Pirini F; Pittureri C; Amaducci E; Guidi L; Faedi M; Amadori D; Falcini F; Calistri D
Int J Biol Markers; 2016 Dec; 31(4):e461-e465. PubMed ID: 27516001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
